Literature DB >> 6830157

Is Alzheimer disease caused by lack of nerve growth factor?

F Hefti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6830157     DOI： 10.1002/ana.410130127

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  18 in total

1.  Progression of tau pathology in cholinergic Basal forebrain neurons in mild cognitive impairment and Alzheimer's disease.

Authors:  Laurel Vana; Nicholas M Kanaan; Isabella C Ugwu; Joanne Wuu; Elliott J Mufson; Lester I Binder
Journal:  Am J Pathol       Date:  2011-09-23       Impact factor: 4.307

2.  Hypothesis: microtubules, a key to Alzheimer disease.

Authors:  S S Matsuyama; L F Jarvik
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  Infusion of nerve growth factor (NGF) into kitten visual cortex increases immunoreactivity for NGF, NGF receptors, and choline acetyltransferase in basal forebrain without affecting ocular dominance plasticity or column development.

Authors:  M A Silver; M Fagiolini; D C Gillespie; C L Howe; M G Frank; N P Issa; A Antonini; M P Stryker
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

4.  The earliest tau dysfunction in Alzheimer's disease? Tau phosphorylated at s422 as a toxic seed.

Authors:  Kellen Voss; John Koren; Chad A Dickey
Journal:  Am J Pathol       Date:  2011-09-28       Impact factor: 4.307

5.  A brown alga Sargassum fulvellum facilitates neuronal maturation and synaptogenesis.

Authors:  Md Abdul Hannan; Ji-Young Kang; Yong-Ki Hong; Hyunsook Lee; Muhammad Tanvir Hossain Chowdhury; Jae-Suk Choi; In Soon Choi; Il Soo Moon
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-08-15       Impact factor: 2.416

6.  Progression of tau pathology within cholinergic nucleus basalis neurons in chronic traumatic encephalopathy: A chronic effects of neurotrauma consortium study.

Authors:  Elliott J Mufson; Sylvia E Perez; Muhammad Nadeem; Laura Mahady; Nicholas M Kanaan; Eric E Abrahamson; Milos D Ikonomovic; Fiona Crawford; Victor Alvarez; Thor Stein; Ann C McKee
Journal:  Brain Inj       Date:  2016       Impact factor: 2.311

Review 7.  Advances in the pharmacotherapy of Alzheimer's disease.

Authors:  J C Soares; S Gershon
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

8.  Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection.

Authors:  L R Williams; S Varon; G M Peterson; K Wictorin; W Fischer; A Bjorklund; F H Gage
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

9.  Cortical neurons express nerve growth factor receptors in advanced age and Alzheimer disease.

Authors:  E J Mufson; J H Kordower
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

10.  An integral approach to the etiopathogenesis of human neurodegenerative diseases (HNDDs) and cancer. Possible therapeutic consequences within the frame of the trophic factor withdrawal syndrome (TFWS).

Authors:  Salvador Harguindey; Gorka Orive; Ramón Cacabelos; Enrique Meléndez Hevia; Ramón Díaz de Otazu; Jose Luis Arranz; Eduardo Anitua
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.